Lemaitre Vascular Inc. (LMAT) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Lemaitre Vascular’s revenue went from $89M in fiscal 2016 to $250M in fiscal 2025, growth of about 12.1% a year.
Net income in fiscal 2025 was $58M, a net margin of 23.1%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $269M and net income $63M.
Free cash flow was $74M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 19% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $269M | $250M | $220M | $193M | $162M | $154M | $129M | $117M | $106M | $101M | $89M |
| Gross profit | $194M | $179M | $151M | $127M | $105M | $101M | $85M | $80M | $74M | $71M | $63M |
| Operating income | $75M | $68M | $52M | $37M | $27M | $36M | $29M | $21M | $28M | $21M | $16M |
| Net income | $63M | $58M | $44M | $30M | $21M | $27M | $21M | $18M | $23M | $17M | $11M |
| EPS (diluted) | $2.75 | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 | $1.04 | $0.88 | $1.13 | $0.86 | $0.55 |
| R&D | $17M | $14M | $16M | $17M | $13M | $12M | $10M | $9M | $8M | $7M | $6M |
| Revenue growth | — | +13.5% | +13.6% | +19.7% | +4.7% | +19.4% | +10.3% | +11.1% | +4.7% | +13.1% | +13.8% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $76M | $81M | $44M | $37M | $25M | $35M | $35M | $14M | $20M | $23M | $17M |
| Capital spending | -$9M | -$7M | -$7M | -$7M | -$3M | -$5M | -$3M | -$4M | -$3M | -$6M | -$3M |
| Free cash flow | $67M | $74M | $37M | $29M | $22M | $30M | $32M | $10M | $16M | $16M | $14M |
| Dividends paid | $22M | $18M | $14M | $12M | $11M | $9M | $8M | $7M | $5M | $4M | $3M |
| Buybacks | $2M | $2M | $2M | $853000 | $642000 | $802000 | $570000 | $683000 | $741000 | $778000 | $311000 |
| Stock-based pay | $8M | $8M | $7M | $5M | $4M | $3M | $3M | $3M | $2M | $2M | $2M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $359M | $300M | $105M | $83M | $70M | $27M | $12M | $26M | $19M | $24M |
| Debt | — | $186M | $186M | $19M | $17M | $16M | $52M | $16M | — | — | — |
| Equity | — | $394M | $337M | $298M | $268M | $254M | $173M | $148M | $130M | $110M | $88M |
| Total assets | — | $616M | $552M | $347M | $310M | $293M | $253M | $188M | $153M | $126M | $102M |
| Shares (diluted) | 23M | 23M | 23M | 22M | 22M | 21M | 20M | 20M | 20M | 20M | 19M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 72.0% | 71.5% | 68.6% | 65.7% | 64.9% | 65.6% | 65.4% | 68.1% | 70.0% | 70.1% | 70.6% |
| Operating margin | 27.7% | 27.2% | 23.8% | 19.0% | 16.6% | 23.6% | 22.2% | 18.1% | 26.7% | 20.9% | 18.3% |
| Net margin | 23.5% | 23.1% | 20.0% | 15.6% | 12.8% | 17.4% | 16.4% | 15.3% | 21.7% | 17.0% | 11.9% |
| FCF margin | 24.9% | 29.8% | 16.9% | 15.2% | 13.7% | 19.6% | 24.6% | 8.9% | 15.6% | 16.3% | 15.8% |
| ROIC | — | 9.0% | 7.7% | 8.8% | 7.1% | 10.6% | 9.9% | 10.7% | 17.5% | 15.7% | 12.2% |
| ROE | — | 14.7% | 13.1% | 10.1% | 7.7% | 10.6% | 12.3% | 12.1% | 17.6% | 15.7% | 12.1% |
Frequently asked questions
What is Lemaitre Vascular’s annual revenue?
$250M in fiscal 2025 and $269M over the twelve months to September 30, 2026.
How much profit does Lemaitre Vascular make?
Net income was $58M in fiscal 2025 (net margin 23.1%).
Is Lemaitre Vascular’s revenue growing?
Yes: revenue rose 13.5% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.